Find Academic Supervisors

Mary Rusckowski, PhD, is an Associate Professor in the Department of Radiology at UMass Chan Medical School and holds an additional appointment at the T.H. Chan School of Medicine. Her research focuses on developing novel radiopharmaceuticals and molecular imaging agents for cancer, infection, and other diseases. Education: BA in Biology, Albertus Magnus College PhD in Biochemistry, Rutgers University Research Interests: Rusckowski's work integrates chemistry, biology, and imaging to create targeted diagnostic and therapeutic agents. Her major areas include: Design of radiolabeled antisense oligonucleotides for infection and cancer imaging Pretargeting strategies using morpholino oligomers and complementary chemistry Nanoparticle-based delivery systems for theranostics Development of novel chelators and radiolabeling techniques for technetium, indium, and lutetium isotopes Publication Trends: Her extensive publication record (1997–2024) reveals a consistent focus on advancing nuclear medicine and molecular imaging. Recent works emphasize infection-specific imaging agents, VEGF-targeted radiotherapy, and precision delivery systems for dermatological and neurological applications. Labs and Collaborations: While specific lab names are not provided, her co-authorship network includes prominent researchers such as Dale Greiner, John Harris, and Robert Brown, indicating active collaboration within UMass Chan and beyond.

• Molecular Imaging
• Radiopharmaceuticals
• Cancer Targeting
• +7 more

E. Thomas (Tommy) Pashuck is an Assistant Professor in the Department of Bioengineering at Lehigh University , where he joined after postdoctoral training at Rutgers University and Imperial College London . His research focuses on designing enzyme-responsive biomaterials using peptide self-assembly to control hydrogel chemistry and nanoscale organization , aiming to improve regenerative medicine applications. Education: Ph.D. in Materials Science from Northwestern University (2009) Pashuck's work explores biomaterials that direct cell behavior through precise spatial and mechanical cues . Recent publications highlight advancements in high-throughput peptide screening , 4D bioprinting , and protease-activated hydrogels , demonstrating his expertise in dynamic biomaterial design and cell-matrix interactions . His research group investigates cell adhesion optimization via ligand mobility control , enzyme-mimicking nanomaterials , and sequence-controlled polymerization while maintaining clinical translation goals. Publications from 2021-2025 emphasize hydrogel mechanics , biodegradable scaffolds , and supramolecular catalytic systems , spanning biomaterial engineering , peptide nanotechnology , and regenerative medicine .

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +6 more

Everett A. Lipman is an Associate Professor in the Department of Physics at the University of California, Santa Barbara. His research focuses on experimental biological physics, particularly using single-molecule techniques to study protein folding, DNA synthesis, and molecular motors. Dr. Lipman received his B.A. in Physics with Honors from the University of Chicago in 1991, followed by his M.A. (1993) and Ph.D. (1998) in Physics from UC Berkeley. His doctoral work, "Studies of Evolved Stars with a Mid-Infrared Interferometer," was supervised by Professor Charles Townes and Dr. William Danchi. Lipman's research interests span several areas of biophysics including protein folding dynamics, single-molecule spectroscopy, DNA synthesis mechanisms, and nanoscale optical devices. His work has significantly advanced our understanding of molecular processes at the single-molecule level, particularly in elucidating the mechanisms of protein folding and the operation of molecular motors. He has developed innovative techniques such as nanoscale optical encoders for tracking molecular processes with unprecedented precision. His publication record demonstrates consistent contributions to high-impact journals including Nature, Science, PNAS, and the Journal of Physical Chemistry. His research has evolved from early work in astrophysics (infrared interferometry) to his current focus on biological physics, showing remarkable interdisciplinary breadth. Hellman Family Foundation Faculty Fellow (2008) UCSB Department of Physics Outstanding Teaching Award (2008) UCSB Residence Halls Association Outstanding Professor (2005-2006) Alfred P. Sloan Research Fellow (2005) National Science Foundation Graduate Fellow (1991-1994) Member, United States Physics Olympiad Team (1987) Dr. Lipman has mentored several graduate students to completion of their PhDs, including Charles E. Wickersham (2010) and Shawn H. Pfeil (2009). His research has been supported by prestigious organizations including the Hellman Foundation, Sloan Foundation, National Science Foundation, and HFSP. He teaches advanced physics courses including Physics 128 and Physics 129, focusing on computational methods and experimental techniques in physics.

• Experimental Biological Physics
• Single-Molecule Spectroscopy
• Protein Folding
• +4 more

Kelly Burke is an Associate Professor and Department Head at the University of Connecticut’s College of Engineering. She holds a Ph.D. in Polymer Science from Case Western Reserve University (2010). Her research focuses on synthesizing functional polymeric materials, including liquid crystalline materials, stimuli-responsive polymers, and biocompatible biomaterials for medical and sustainability applications. She has held leadership roles such as Director of the Polymer Science Program (2021–2024) and previously served as an Assistant Professor (2014–2021) and Postdoctoral Scholar (2010–2013) at Tufts University. Burke has received prestigious awards, including the NIH MIRA (2022) and NSF CAREER (2020) awards. Education: Ph.D., Case Western Reserve University, 2010 Research Interests: Her lab explores liquid crystalline polymers for shape-memory applications, biopolymers like silk for medical devices, and materials to modulate inflammation. Projects include biodegradable linkers in liquid crystalline networks and functionalized silk surfaces for drug delivery. Research areas span biomaterials engineering, sustainable polymers, and regenerative medicine. Publications: Her work spans liquid crystalline materials, silk-based adhesives, and biomedical applications. Recent studies include 3D-printed silk constructs for tissue engineering and electrocaloric polymers for energy applications. Awards: National Institutes of Health Maximizing Investigators’ Research Award (2022) American Chemical Society Young Investigator Award (2022) National Science Foundation CAREER Award (2020) Grants & Labs: Leads the Burke Laboratory for Polymeric Materials, focusing on advanced materials for medical and sustainable uses. Her NSF and NIH grants support research into shape-memory polymers and biomaterials for chronic disease modulation. Labs/Teams: The Burke Lab collaborates on projects involving silk fibroin conjugates, electrocaloric materials, and biocompatible composites. Facilities include advanced characterization tools for polymer synthesis and biomaterial testing.

• Polymer Science
• Biomaterials
• Liquid Crystalline Materials
• +3 more

Irene A. Chen is a Professor in the Department of Biochemistry at the University of California, Los Angeles (UCLA) , within the Henry Samueli School of Engineering and Applied Science (SEAS) . She leads the Chen Laboratory , which focuses on biomolecular design and evolution in nanoscale systems , including protocells and bacteriophages . Her research spans synthetic biology , origin of life , RNA evolution , phage engineering , and antimicrobial applications . Her lab uses in vitro evolution , high-throughput sequencing , and nanomaterial-bioconjugation to explore how life-like systems can be constructed and controlled. Research Interests: Biomolecular design and evolution in nanoscale systems Protocell formation and RNA encapsulation Bacteriophage engineering for antimicrobial therapy Fitness landscapes in RNA evolution Phage-nanoparticle conjugates for imaging and therapy Recent Work Trends: Her recent publications (2024–2025) reflect a strong focus on phage-based therapeutics , protocell systems , and RNA evolution . Many papers explore antimicrobial applications using engineered phages, nanoparticle conjugates , and RNA catalysis in prebiotic contexts. Scientific Awards: No specific awards are listed in the provided text. Grants & Funding: While no specific grant details are provided, her extensive publication record and lab operations suggest active funding from NIH, NSF, or other biomedical engineering and synthetic biology programs. Laboratory & Team: The Chen Laboratory is located at UCLA SEAS and focuses on interdisciplinary research combining chemistry , biology , and engineering to address fundamental questions in origin of life and antimicrobial innovation .

• Biomolecular Design
• Synthetic Biology
• Origin of Life
• +5 more

Tracy Brooks is the Chair and Associate Professor of Pharmaceutical Sciences at Binghamton University's School of Pharmacy and Pharmaceutical Sciences, holding the Menner Family Endowed Faculty Fellowship. She specializes in oncology and anti-cancer therapeutics, focusing on drug target development through DNA and protein interactions. Her research emphasizes G-quadruplex stabilization in oncogene promoters to regulate transcription, with applications in pancreatic, prostate, and breast cancers. Education: Bachelor of Science (BS) from the University of Rochester Doctor of Philosophy (PhD) from the University at Buffalo (SUNY) Research Interests: Tracy's work centers on developing novel therapies targeting oncogenes like KRAS and MYC. She explores G-quadruplex structures in promoter regions to inhibit cancer cell proliferation, leveraging small molecules and oligonucleotides. Her lab also investigates nucleic acid delivery systems and the role of epigenetic modifications (e.g., 5-hydroxymethylcytosine) in DNA structure stability. Recent Article Trends: Her publications (2020–2025) highlight advancements in G-quadruplex ligand design, antibody-drug conjugates (ADCs), and combinatorial therapies targeting KRAS/MYC pathways. Key themes include optimizing ADC stability, validating G-quadruplex-based approaches for pancreatic cancer, and exploring transcriptional control mechanisms. Awards: Inaugural Menner Family Endowed Faculty Fellow (2017) Advising & Grants: While specific grant details are not listed, her research has consistently addressed translational oncology challenges. She advises students on projects involving molecular pharmacology and drug delivery, emphasizing cross-disciplinary approaches. Labs & Teams: Her lab focuses on translational cancer research, collaborating with institutions like the University of Arizona and University of Mississippi on drug development and mechanistic studies.

• Oncology
• Anti-cancer therapeutics
• Drug target development
• +3 more

Bradley L. Pentelute is a Professor of Chemistry at the Massachusetts Institute of Technology (MIT) , affiliated with the School of Science and the Department of Chemistry . His research focuses on developing advanced chemical tools for protein modification, drug delivery, and rapid biopolymer synthesis. The Pentelute Lab pioneers technologies like automated flow chemistry for protein synthesis and engineered anthrax toxin-based delivery systems. Research Interests: The lab invents chemistries to modify proteins for therapeutic applications, such as antibody-drug conjugates and cell-penetrating peptides. They also develop fast-flow synthesis platforms to produce large proteins and study protein-protein interactions using affinity selection-mass spectrometry. Key areas include peptide macrocycles , mirror-image proteins , and antisense delivery . Recent Work: The 2025 publications highlight advancements in automated synthesis of immune checkpoint receptors (PD-1/PD-L1), mirror-image proteins (e.g., cyclophilin A), and affinity selection techniques. Earlier work includes breakthroughs in anthrax toxin-mediated delivery of antisense oligonucleotides and ultra-fast protein synthesis. Labs & Teams: The Pentelute Lab collaborates widely, leveraging MIT’s resources to bridge chemistry, biology, and engineering. Ongoing projects include developing brain-penetrant therapeutics and machine learning-aided peptide design.

• Chemical Biology
• Peptide Chemistry
• Protein Engineering
• +3 more

Kevin Edgar is a Professor of Biomaterials and Bioprocessing and Director of the ICTAS Bio-Based Materials Center at Virginia Tech's College of Natural Resources and Environment, Department of Sustainable Biomaterials. With a Ph.D. in Organic Chemistry from Duke University (1979) and a B.S. in Chemistry from Bucknell University (1975), he has established himself as a leading researcher in polysaccharide chemistry and sustainable biomaterials. Dr. Edgar's research focuses on designing and creating derivatives of natural polysaccharides to address demanding performance requirements, exploring structure-property-performance relationships for applications including drug-delivery systems, tissue engineering, biodegradable plastics, polymer compatibilization, hydrogels, and block copolymers. His work specifically targets novel methods to control and utilize the nanostructure of polysaccharides, with emphasis on regioselective substitution reactions of complex polysaccharides. He investigates how to effectively utilize natural polysaccharides to address societal needs, leveraging their diverse natural functions from structural support to information storage. Analysis of his recent publications reveals a strong focus on hydrogel development, drug delivery systems, and polysaccharide modification techniques. His work spans fundamental chemistry of polysaccharides to applied pharmaceutical and medical applications, with particular emphasis on creating sustainable alternatives to fossil fuel-based materials. The research demonstrates consistent innovation in regioselective synthesis methods and structure-property relationships of polysaccharide derivatives. 2023 Appointed to Virginia Tech Academy of Faculty Leadership 2022 Virginia Tech College of Natural Resources and Environment Outstanding Graduate Student Mentor Award 2016 Anselme Payen Award for outstanding professional contributions to cellulose science 2010 Named Fellow of the ACS Division of Cellulose and Renewable Materials 2009 Named Fellow of ACS (inaugural class of ACS Fellows) Dr. Edgar has mentored numerous graduate students through their Ph.D. and Master's research, with many receiving prestigious awards including multiple Eastman Awards for outstanding graduate students. His research has been supported by significant grants from NSF, USDA NIFA, and other funding agencies. He leads the ICTAS Bio-Based Materials Center and co-directs the Infectious Disease Interdisciplinary Graduate Education Program, demonstrating strong leadership in interdisciplinary research. His lab actively develops sustainable biomaterials with applications in drug delivery, tissue engineering, and environmental health.

• Polysaccharide Chemistry
• Drug Delivery Systems
• Tissue Engineering
• +7 more

Jeffrey Wang is Professor of Biotechnology and Pharmaceutical Sciences and Associate Dean for Research and Global Advancement at Western University of Health Sciences' College of Pharmacy. He holds a PhD in Pharmaceutical Sciences from University of Southern California (1995) and B.S. in Pharmacy from Shanghai Medical University (1986). His research focuses on drug delivery systems, prodrug design, and nanotechnology applications in pharmaceuticals. Key research areas include reversible lipidization of biomolecules, oral peptide delivery, and nanoparticle formulation development. He has led/co-led numerous grants including NIH-funded studies on pancreatic cancer nanotherapy (2014-2017) and chemoresistance mechanisms (2016-2017). Notable achievements include 4 patents related to drug delivery innovations and over 10 peer-reviewed publications in journals like Drug Delivery and Translational Research and Nanoscale . Recent work emphasizes synergistic drug combinations (e.g., loratadine-SMEDDS/sulforaphane for pancreatic cancer) and silk fibroin nanoparticle systems. His educational contributions include curriculum development for pharmacokinetics courses. Current projects involve preclinical development of factor IX-based hemophilia therapies and novel formulations for antibiotics like vancomycin. Key grants: NIH R15 (pancreatic cancer nanotherapy), Strategic Drug Solutions (nasal spray bioavailability study) Labs/Teams: Collaborates with Eureka BioVenture on silkworm drug models and Novo Nordisk on hemophilia B therapies

• Reversible lipidization of proteins/peptides
• Oral drug delivery
• Bioconjugation chemistry
• +6 more

Valery Fokin is a Professor of Chemistry at the University of Southern California (USC), Department of Chemistry. His research focuses on organic synthesis with applications in chemical biology, particularly in click chemistry, antidote development, and bioconjugation. He holds a Ph.D. from USC (1998) and has contributed extensively to the design of novel synthetic methods and bioactive molecules. His work spans drug discovery, catalysis, and the development of reagents for toxicology applications. Notable contributions include advancements in azide-alkyne cycloaddition (CuAAC) and sulfur fluoride exchange (SuFEx) reactions, which have broad implications in medicinal chemistry and materials science. His lab explores strategies to create efficient organophosphate antidotes and antimicrobial agents targeting drug-resistant pathogens. Publications highlight innovations in microdroplet chemistry, enzyme reactivation mechanisms, and the synthesis of heterocyclic compounds. Fokin’s research bridges academic and industrial collaboration, as seen in studies on cannabinoid-derived drug potential and scalable synthesis methods. His team actively pursues applications in drug delivery and tissue-specific targeting. While no specific awards or grants are listed, his prolific publication record reflects sustained contributions to chemical biology. His advising and lab activities emphasize interdisciplinary approaches to solving biomedical challenges through innovative organic synthesis.

• Organic Chemistry
• Chemical Biology
• Drug Discovery
• +5 more

Nathaniel Rosi is the Covestro Professor of Chemistry at the University of Pittsburgh's Dietrich School of Arts and Sciences, Department of Chemistry. His research focuses on designing and synthesizing new materials using chemical building blocks like metal clusters and biomolecules to create hierarchical structures with tailored properties for energy, medicine, and other applications. Research interests span inorganic and materials chemistry, metal-organic frameworks (MOFs), nanoparticle assembly, and sustainable energy materials. The Rosi Lab develops unifying design principles for organizing building blocks across multiple length scales, employing diverse synthetic methods and characterization techniques including NMR, TEM, X-ray diffraction, and sorption analysis. Scientific awards include: Chancellor's Distinguished Research Award (2014) Kavli Fellow (2012) ChemComm Emerging Investigator (2011) NSF CAREER Award (2010-2015) US Delegate for Transatlantic Frontiers of Chemistry Conference (2008) The Rosi Research Laboratory trains students in interdisciplinary approaches at the chemistry-biophysics interface and welcomes graduate students to explore its multi-disciplinary research environment.

• Inorganic Chemistry
• Materials Chemistry
• Metal-Organic Frameworks
• +2 more

Martin H. Wühr is an Associate Professor of Molecular Biology and a member of the Lewis-Sigler Institute for Integrative Genomics at Princeton University. He leads the Wuhr Lab, focusing on quantitative proteomics to understand cellular organization. His work investigates how molecules self-organize into organelles and cells, particularly studying nuclear-cytoplasmic proteome partitioning and its impact on biological function. Research employs mass spectrometry-based proteomics combined with computational, biochemical, and imaging approaches, using models like human tissue cells and Xenopus laevis embryos. Key contributions include analyzing protein localization dynamics during embryogenesis and developing novel proteomic methodologies. Recent publications highlight advancements in multiplexed proteomics, nuclear import mechanisms, and microbial nutrient interactions. Awards and grants are not explicitly listed, but his lab’s technical innovations indicate significant field impact. Advising and lab management details are not provided, though collaborations with institutions like MIT and Harvard suggest active academic engagement. Labs/Teams: The Wuhr Lab at Princeton University focuses on systems-level proteomics and cellular organization studies.

• Proteomics
• Cellular Organization
• Molecular Biology
• +3 more

Fang Lu serves as Staff Scientist at Brookhaven National Laboratory's Center for Functional Nanomaterials (2012-present) and Adjunct Professor at Stony Brook University (2021-present), focusing on nanomaterial synthesis for energy applications. Education Ph.D. in Condensed Matter Physics, Chinese Academy of Sciences, China Research Focus Dr. Lu pioneers shape/size-controllable nanoparticle synthesis (Au, Ag, Pd, Pt) and multi-component nanostructures using DNA-driven assembly. His work bridges structural characterization (SAXS/EM) with functional applications in electrocatalysis and plasmonics, targeting energy-conversion materials. Expertise spans particle surface modification, collective optical properties, and biomolecule functionalization. Publication Trends Recent publications (2023-2025) reveal evolution from fundamental synthesis toward applied energy systems: DNA-mediated chiral nanomaterials for sensing, facet-specific electrocatalysis (e.g., glycerol oxidation), and perovskite solar cell enhancements. Consistent themes include nanocrystal interface engineering and translating structural control into functional properties. Laboratory Context At Brookhaven's Center for Functional Nanomaterials, Dr. Lu utilizes state-of-the-art nanofabrication and characterization facilities within a multidisciplinary team advancing energy, quantum, and biological nanotechnology research.

• Nanomaterials
• Nanoparticle Synthesis
• Self-assembly
• +5 more

Bill Boggess is a Research Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, where he also serves as Director of the Mass Spectrometry & Proteomics Facility (MSPF). The facility supports interdisciplinary research through advanced analytical services including GC/MS, LC/MS, high-resolution mass spectrometry, and various ionization methods. His research interests are centered in analytical and physical chemistry , with a strong emphasis on measurement science, instrumentation, and proteomics . The MSPF acts as a critical resource for both internal and external researchers, enabling high-precision analyses across chemistry, biology, and materials science. The selected publications highlight the broad application of mass spectrometry in areas such as immunology, materials chemistry, neurobiology, and nanomaterials. These works demonstrate a consistent role in supporting cutting-edge research through analytical expertise rather than leading independent biological discovery. Beyond publications, Dr. Boggess manages a core facility integral to Notre Dame's research infrastructure, providing training, collaboration, and access to state-of-the-art instrumentation. The MSPF is a designated Indiana CTSI Core Facility, underscoring its regional importance. The facility operates through the iLab system for service requests and is open to outside collaborators. Instrument access follows strict scheduling and remote data handling protocols, especially post-COVID-19 reopening. Ph.D., University of Tennessee, 1994 B.S., Davis & Elkins College, 1988 He advises no formal students listed, but supports numerous graduate and postdoctoral researchers through collaborative projects. No scientific awards are mentioned in the provided text. Dr. Boggess leads the Mass Spectrometry & Proteomics Facility, a core research unit in McCourtney Hall, providing analytical support, training, and instrumentation access to researchers across disciplines. The facility offers services in chromatography, mass spectrometry, and data analysis, and serves as an Indiana CTSI-designated core.

• Analytical Chemistry
• Physical Chemistry
• Mass Spectrometry
• +4 more

Theresa Reineke is a Distinguished McKnight University Professor in the Department of Chemistry at the University of Minnesota, with additional appointments as Graduate Faculty in the Department of Pharmaceutics and Graduate Faculty Advisor in the Department of Chemical Engineering and Materials Science within the College of Science and Engineering. She also serves as Associate Editor for ACS Macro Letters. PhD in Chemistry, University of Michigan MS in Chemistry, Arizona State University BS in Chemistry/Physics, University of Wisconsin-Eau Claire NIH Post-Doctoral Fellow, California Institute of Technology, Division of Chemistry and Chemical Engineering Professor Reineke's research focuses on the development of novel polymeric materials for biomedical applications, particularly in the areas of gene delivery and therapeutic nucleic acid delivery. Her work bridges polymer chemistry, biomaterials science, and pharmaceutical sciences, with an emphasis on creating nonviral delivery systems that can effectively transport genetic material to target cells. Her research group explores the design, synthesis, and characterization of cationic glycopolymers and other advanced polymeric systems for therapeutic applications. Analysis of Professor Reineke's recent publications reveals a strong focus on polymeric delivery systems for nucleic acids, with particular emphasis on nonviral gene delivery vectors. Her work spans fundamental polymer chemistry to applied biomedical research, with recent publications covering topics from radical ring-opening polymerization of sustainable monomers to blended block polycation micelles for antisense oligonucleotide delivery. The research demonstrates a consistent trajectory toward developing more efficient and targeted delivery systems for genetic therapies. Distinguished McKnight University Professor Professor Reineke maintains an active research program with numerous publications in high-impact journals. She serves in editorial roles, including as Associate Editor for ACS Macro Letters, and appears to be actively mentoring students and postdoctoral researchers through her research group. Her interdisciplinary approach connects chemistry, chemical engineering, and pharmaceutical sciences to address challenges in therapeutic delivery. Professor Reineke leads the Reineke Research Group, which focuses on developing innovative polymeric materials for biomedical applications, particularly in the area of gene therapy and nucleic acid delivery. The group employs a multidisciplinary approach combining synthetic chemistry, materials science, and biological evaluation to create next-generation delivery systems.

• Polymer Chemistry
• Gene Delivery
• Bioconjugate Chemistry
• +7 more